COVID-19 Vaccination Linked to Reduced Mortality and Potential Increased Cancer Risk

Strategic Insights -

Researchers from the University of Bologna conducted a 30-month cohort study in an Italian province, analyzing the association between SARS-CoV-2 vaccination and cancer hospitalization. The study involved 296,015 residents, with 16.6% unvaccinated, 83.3% receiving one dose, and 62.2% receiving three doses. The findings indicated that individuals receiving at least one dose of the vaccine showed a significantly lower likelihood of all-cause death and a slightly higher likelihood of hospitalization for cancer compared to the unvaccinated group. However, this increased risk was only significant among those without a previous SARS-CoV-2 infection and reversed when the minimum time between vaccination and cancer hospitalization was set to 12 months.

Key Takeaways:

  • The study involved a population-wide cohort analysis of 296,015 residents in the Pescara province, Italy, from June 2021 to December 2023.
  • The research found that individuals receiving at least one dose of the vaccine showed a significantly lower likelihood of all-cause death compared to the unvaccinated group.
  • Those receiving at least one dose showed a slightly higher likelihood of hospitalization for cancer, but this association was only significant among subjects with no previous SARS-CoV-2 infection.
  • The increased risk of cancer hospitalization was reversed when the minimum time between vaccination and cancer hospitalization was set to 12 months.
  • The study concluded that the findings are preliminary and that the potential impact of the healthy vaccinee bias and unmeasured confounders cannot be quantified.
  • The research highlighted the need for further investigation into the association between SARS-CoV-2 vaccination and cancer hospitalization.

Statistics:

  • The study involved 296,015 residents in the Pescara province, Italy.
  • Among the residents, 16.6% were unvaccinated, 83.3% received at least one dose, and 62.2% received three doses.
  • The study found that individuals receiving at least one dose showed a hazard ratio (HR) of 1.23 (95% CI: 1.11-1.37) for hospitalization for cancer compared to the unvaccinated group.
  • The increased risk of cancer hospitalization was only significant among subjects with no previous SARS-CoV-2 infection.

Sources:

  • Excli Journal, Covid-19 Vaccination, All-cause Mortality, and Hospitalization for Cancer: 30-month Cohort Study In an Italian Province.
  • University of Bologna, Dept. of Medical and Surgical Sciences.
  • Excli Journal Managing Office, Leibniz Research Centre Working Environment & Human Factors Excli Journal, Ardeystr 67, Dortmund, D-44139, Germany.